Advisory Commission of Childhood Vaccines; Request for Nominations for Voting Members, 61372-61373 [2013-24304]
Download as PDF
61372
Federal Register / Vol. 78, No. 192 / Thursday, October 3, 2013 / Notices
Massachusetts, Court of Federal
Claims No: 13–0611V
45. Mordichai and Chana Pshemish on
behalf of Y.P., Boca Raton, Florida,
Court of Federal Claims No: 13–
0612V
46. Bryan Krehnbrink, Boston,
Massachusetts, Court of Federal
Claims No: 13–0613V
47. Saro Manoukian, Worcester,
Massachusetts, Court of Federal
Claims No: 13–0614V
48. Howard S. Kahn, Baraboo,
Wisconsin, Court of Federal Claims
No: 13–0615V
49. James E. Smith, Lake City,
Tennessee, Court of Federal Claims
No: 13–0617V
50. John Ryng, Bristol, Connecticut,
Court of Federal Claims No: 13–
0618V
51. Ruth Day, Denton, Texas, Court of
Federal Claims No: 13–0620V
52. Latasha George, Lake Charles,
Louisiana, Court of Federal Claims
No: 13–0621V
53. Danya Wright, Tarrant, Texas, Court
of Federal Claims No: 13–0622V
54. Joseph Wojtanowski, Providence,
Rhode Island, Court of Federal
Claims No: 13–0623V
55. Cynthia M. Morris (Sabin), Dekalb,
Illinois, Court of Federal Claims No:
13–0624V
56. Steven Carpenter, Lander, Wyoming,
Court of Federal Claims No: 13–
0628V
57. Cathy L. Jackson, Raleigh, North
Carolina, Court of Federal Claims
No: 13–0630V
58. Douglas Orton on behalf of Walter J.
Orton, III, Deceased, Grand Island,
New York, Court of Federal Claims
No: 13–0631V
[FR Doc. 2013–24220 Filed 10–2–13; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Advisory Commission of Childhood
Vaccines; Request for Nominations for
Voting Members
Health Resources and Services
Administration, HHS.
ACTION: Notice.
tkelley on DSK3SPTVN1PROD with NOTICES
AGENCY:
The Health Resources and
Services Administration (HRSA) is
requesting nominations of qualified
candidates to fill three vacancies on the
Advisory Commission on Childhood
Vaccines (ACCV). The ACCV was
established by Title XXI of the Public
SUMMARY:
VerDate Mar<15>2010
18:29 Oct 02, 2013
Jkt 232001
Health Service Act (the Act), as enacted
by Public Law (Pub. L.) 99–660 and as
subsequently amended, and advises the
Secretary of Health and Human Services
(the Secretary) on issues related to
implementation of the National Vaccine
Injury Compensation Program (VICP).
DATES: The agency must receive
nominations on or before 60 days after
date of publication in the Federal
Register.
ADDRESSES: All nominations are to be
submitted to the Director, Division of
Vaccine Injury Compensation,
Healthcare Systems Bureau (HSB),
HRSA, Parklawn Building, Room
11C–26, 5600 Fishers Lane, Rockville,
Maryland 20857.
FOR FURTHER INFORMATION CONTACT: Ms.
Amber Berrian, Principal Staff Liaison,
Division of Vaccine Injury
Compensation, HSB, HRSA, at (301)
443–0845 or email aberrian@hrsa.gov.
SUPPLEMENTARY INFORMATION: Under the
authorities that established the ACCV,
the Federal Advisory Committee Act of
October 6, 1972 (Pub. L. 92–463) and
section 2119 of the Act, 42 U.S.C. 300aa19, as added by Public Law 99–660 and
amended, HRSA is requesting
nominations for three voting members
of the ACCV.
The ACCV advises the Secretary on
the implementation of the VICP. The
activities of the ACCV include:
Recommending changes in the Vaccine
Injury Table at its own initiative or as
the result of the filing of a petition;
advising the Secretary in implementing
section 2127 regarding the need for
childhood vaccination products that
result in fewer or no significant adverse
reactions; surveying federal, state, and
local programs and activities related to
gathering information on injuries
associated with the administration of
childhood vaccines, including the
adverse reaction reporting requirements
of section 2125(b); advising the
Secretary on the methods of obtaining,
compiling, publishing, and using
credible data related to the frequency
and severity of adverse reactions
associated with childhood vaccines;
consulting on the development or
revision of the Vaccine Information
Statements; and recommending to the
Director of the National Vaccine
Program that vaccine safety research be
conducted on various vaccine injuries.
The ACCV consists of nine voting
members appointed by the Secretary as
follows: (1) Three health professionals,
who are not employees of the United
States Government and have expertise
in the health care of children, and the
epidemiology, etiology, and prevention
of childhood diseases, and the adverse
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
reactions associated with vaccines, at
least two shall be pediatricians; (2) three
members from the general public, at
least two shall be legal representatives
(parents or guardians) of children who
have suffered a vaccine-related injury or
death; and (3) three attorneys, at least
one shall be an attorney whose specialty
includes representation of persons who
have suffered a vaccine-related injury or
death, and one shall be an attorney
whose specialty includes representation
of vaccine manufacturers. In addition,
the Director of the National Institutes of
Health, the Assistant Secretary for
Health, the Director of the Centers for
Disease Control and Prevention, and the
Commissioner of the Food and Drug
Administration (or the designees of such
officials) serve as nonvoting ex officio
members.
Specifically, HRSA is requesting
nominations for three voting members
of the ACCV representing: (1) A health
professional, who has expertise in the
health care of children; and the
epidemiology, etiology, and prevention
of childhood diseases; and (2) a member
of the general public who is the legal
representative (parent or guardian) of a
child who has suffered a vaccine related
injury or death; and (3) an attorney with
no specific affiliation. Nominees will be
invited to serve a 3-year term beginning
January 1, 2014, and ending December
31, 2016.
The Department of Health and Human
Services (HHS) will consider
nominations of all qualified individuals
with a view to ensuring that the ACCV
includes the areas of subject matter
expertise noted above. Individuals may
nominate themselves or other
individuals, and professional
associations and organizations may
nominate one or more qualified persons
for membership on the ACCV.
Nominations shall state that the
nominee is willing to serve as a member
of the ACCV and appears to have no
conflict of interest that would preclude
the ACCV membership. Potential
candidates will be asked to provide
detailed information concerning
financial interests, consultancies,
research grants, and/or contracts that
might be affected by recommendations
of the ACCV to permit evaluation of
possible sources of conflicts of interest.
A nomination package should include
the following information for each
nominee: (1) A letter of nomination
stating the name, affiliation, and contact
information for the nominee, the basis
for the nomination (i.e., what specific
attributes, perspectives, and/or skills
does the individual possess that would
benefit the workings of ACCV), and the
nominee’s field(s) of expertise; (2) a
E:\FR\FM\03OCN1.SGM
03OCN1
Federal Register / Vol. 78, No. 192 / Thursday, October 3, 2013 / Notices
biological sketch of the nominee and a
copy of his/her curriculum vitae; and (3)
the name, address, daytime telephone
number, and email address at which the
nominator can be contacted.
HHS strives to ensure that the
membership of HHS federal advisory
committee is fairly balanced in terms of
points of view presented and the
committees function. Every effort is
made to ensure that the views of
women, all ethnic and racial groups,
and people with disabilities are
represented on HHS federal advisory
committees and, therefore, the
Department encourages nominations of
qualified candidates from these groups.
The Department also encourages
geographic diversity in the composition
of the Committee. Appointment to this
Committee shall be made without
discrimination on basis of age, race,
ethnicity, gender, sexual orientation,
disability, and cultural, religious, or
socioeconomic status.
Dated: September 26, 2013.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2013–24304 Filed 10–2–13; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Animal Center Master Plan Record of
Decision
The Department of Health and
Human Services, the National Institutes
of Health (NIH), has decided, after
completion of a Final Environmental
Impact Statement (FEIS) and a thorough
consideration of the public comments
on the Draft EIS, to implement the
Proposed Action, referred to as the
Proposed Action in the Final EIS. This
action is for a long-range physical
Master Plan for National Institutes of
Health Animal Center (NIHAC) located
in Dickerson, Maryland. This alternative
accounts for potential growth in NIHAC
personnel, new construction, additions,
renovations, demolitions, and upgrades
in site utilities.
Responsible Official: Daniel G.
Wheeland, Director, Office of Research
Facilities Development and Operations,
NIH.
FOR FURTHER INFORMATION CONTACT:
Valerie Nottingham, Deputy Director,
DEP, ORF, NIH, Building 13, Room
2S11, 9000 Rockville Pike, Bethesda,
MD 20892, Phone 301–496–7775,
nihnepa@mail.nih.gov.
SUPPLEMENTARY INFORMATION:
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
18:29 Oct 02, 2013
Jkt 232001
Decision
After careful review of the
environmental consequences in the
Final Environmental Impact Statement
for the Master Plan, National Institutes
of Health Animal Center, and
consideration of public comment
throughout the NEPA process, the NIH
has decided to implement the Proposed
Action described below as the Selected
Alternative.
Selected Alternative
The Selected Alternative is intended
to be a strategic tool for the efficient
allocation of campus resources, the
orderly accommodation of future
growth, and the creation of an
environment, which is both functionally
and aesthetically conducive to
accomplishing the NIHAC mission. The
Selected Alternative will provide a
guide for the reasoned and orderly
development of the NIHAC campus, one
that values and builds on existing
resources, corrects current deficiencies
and meets changing needs through new
construction or renovation. The plan
sets forth implementation priorities and
a logical sequencing of planned
development.
The Selected Alternative is for a longrange physical Master Plan for NIHAC.
This alternative covers a 20-year
planning period, with reviews every 5
years to ensure that the plan continues
to address issues affecting the campus.
The alternative addresses the future
development of the NIHAC site,
including placement of future
construction; vehicular and pedestrian
circulation on and off-campus; parking
within the property boundaries; open
space in and around the campus;
required setbacks; historic properties;
natural and scenic resources; noise; and
lighting. This alternative accounts for
potential growth in NIHAC personnel,
and consequent construction of space
over the planning period. Future
construction on the site could include
such facilities as new animal holding,
research laboratories, and support
facilities.
NIH will continue to develop NIHAC
to accommodate NIH’s research needs
and required programmatic adjacencies
consistent with the commitment to
maintain the ‘‘campus’’ character of the
site. The alternative advances this
objective by programming and locating
future NIHAC growth so that new
development would tie into the existing
utility services and utilities are available
to support growth, and establishing
development guidelines for future
changes to the site that ensure that as
the campus grows new development
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
61373
would be responsive to the context of
adjacent neighborhoods or
developments. Under the selected
alternative, NIHAC’s population is
anticipated to grow in the next twenty
years to a total campus population of
212. The primary growth at the campus
would be in intramural research
personnel and the administrative and
facility staff to support them.
Alternatives Considered
The Proposed Action Alternative and
No Action Alternative were the two
alternatives analyzed in the Final EIS.
The Master Plan covers a 20-year
planning period, but will be reviewed
every 5 years to ensure that the plan
continues to remain current and
relevant to the key issues affecting the
campus. The alternatives addressed the
future development of the NIHAC site,
including placement of future
construction; vehicular and pedestrian
circulation on and off-campus; parking
within the property boundaries; open
space in and around the campus;
required setbacks; historic properties;
natural and scenic resources; noise; and
lighting. They account for potential
growth in NIHAC personnel, and
consequent construction of space over
the planning period. Future
construction on the site could include
such facilities as new animal holding,
research laboratories, and support
facilities.
Factors Involved in the Decision
The Department of Health and Human
Services (HHS) requires that NIH
facilities have a Master Plan; however,
the previous Master Plan for the NIHAC
campus was outdated. In addition,
factors such as the aging of facilities that
were designed only to accommodate
temporary use, animal housing facilities
that do not provide adequate space for
projected increases in animal
populations, and research support
facilities not being adequate to sustain
current and projected programs played
a key role. The Master Plan contains
information and recommendations to
guide development of individual
projects. It also serves as a means of
informing city and county officials and
utilities of future NIHAC development
plans so they can anticipate and plan for
the potential effects of NIHAC proposals
on their systems.
Resources Impacts
The Final EIS describes potential
environmental effects of the Selected
Alternative. These potential effects are
documented in Chapter 3 of the Final
EIS. Any potential adverse
environmental effects will be avoided or
E:\FR\FM\03OCN1.SGM
03OCN1
Agencies
[Federal Register Volume 78, Number 192 (Thursday, October 3, 2013)]
[Notices]
[Pages 61372-61373]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-24304]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Commission of Childhood Vaccines; Request for
Nominations for Voting Members
AGENCY: Health Resources and Services Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Health Resources and Services Administration (HRSA) is
requesting nominations of qualified candidates to fill three vacancies
on the Advisory Commission on Childhood Vaccines (ACCV). The ACCV was
established by Title XXI of the Public Health Service Act (the Act), as
enacted by Public Law (Pub. L.) 99-660 and as subsequently amended, and
advises the Secretary of Health and Human Services (the Secretary) on
issues related to implementation of the National Vaccine Injury
Compensation Program (VICP).
DATES: The agency must receive nominations on or before 60 days after
date of publication in the Federal Register.
ADDRESSES: All nominations are to be submitted to the Director,
Division of Vaccine Injury Compensation, Healthcare Systems Bureau
(HSB), HRSA, Parklawn Building, Room 11C-26, 5600 Fishers Lane,
Rockville, Maryland 20857.
FOR FURTHER INFORMATION CONTACT: Ms. Amber Berrian, Principal Staff
Liaison, Division of Vaccine Injury Compensation, HSB, HRSA, at (301)
443-0845 or email aberrian@hrsa.gov.
SUPPLEMENTARY INFORMATION: Under the authorities that established the
ACCV, the Federal Advisory Committee Act of October 6, 1972 (Pub. L.
92-463) and section 2119 of the Act, 42 U.S.C. 300aa-19, as added by
Public Law 99-660 and amended, HRSA is requesting nominations for three
voting members of the ACCV.
The ACCV advises the Secretary on the implementation of the VICP.
The activities of the ACCV include: Recommending changes in the Vaccine
Injury Table at its own initiative or as the result of the filing of a
petition; advising the Secretary in implementing section 2127 regarding
the need for childhood vaccination products that result in fewer or no
significant adverse reactions; surveying federal, state, and local
programs and activities related to gathering information on injuries
associated with the administration of childhood vaccines, including the
adverse reaction reporting requirements of section 2125(b); advising
the Secretary on the methods of obtaining, compiling, publishing, and
using credible data related to the frequency and severity of adverse
reactions associated with childhood vaccines; consulting on the
development or revision of the Vaccine Information Statements; and
recommending to the Director of the National Vaccine Program that
vaccine safety research be conducted on various vaccine injuries.
The ACCV consists of nine voting members appointed by the Secretary
as follows: (1) Three health professionals, who are not employees of
the United States Government and have expertise in the health care of
children, and the epidemiology, etiology, and prevention of childhood
diseases, and the adverse reactions associated with vaccines, at least
two shall be pediatricians; (2) three members from the general public,
at least two shall be legal representatives (parents or guardians) of
children who have suffered a vaccine-related injury or death; and (3)
three attorneys, at least one shall be an attorney whose specialty
includes representation of persons who have suffered a vaccine-related
injury or death, and one shall be an attorney whose specialty includes
representation of vaccine manufacturers. In addition, the Director of
the National Institutes of Health, the Assistant Secretary for Health,
the Director of the Centers for Disease Control and Prevention, and the
Commissioner of the Food and Drug Administration (or the designees of
such officials) serve as nonvoting ex officio members.
Specifically, HRSA is requesting nominations for three voting
members of the ACCV representing: (1) A health professional, who has
expertise in the health care of children; and the epidemiology,
etiology, and prevention of childhood diseases; and (2) a member of the
general public who is the legal representative (parent or guardian) of
a child who has suffered a vaccine related injury or death; and (3) an
attorney with no specific affiliation. Nominees will be invited to
serve a 3-year term beginning January 1, 2014, and ending December 31,
2016.
The Department of Health and Human Services (HHS) will consider
nominations of all qualified individuals with a view to ensuring that
the ACCV includes the areas of subject matter expertise noted above.
Individuals may nominate themselves or other individuals, and
professional associations and organizations may nominate one or more
qualified persons for membership on the ACCV. Nominations shall state
that the nominee is willing to serve as a member of the ACCV and
appears to have no conflict of interest that would preclude the ACCV
membership. Potential candidates will be asked to provide detailed
information concerning financial interests, consultancies, research
grants, and/or contracts that might be affected by recommendations of
the ACCV to permit evaluation of possible sources of conflicts of
interest.
A nomination package should include the following information for
each nominee: (1) A letter of nomination stating the name, affiliation,
and contact information for the nominee, the basis for the nomination
(i.e., what specific attributes, perspectives, and/or skills does the
individual possess that would benefit the workings of ACCV), and the
nominee's field(s) of expertise; (2) a
[[Page 61373]]
biological sketch of the nominee and a copy of his/her curriculum
vitae; and (3) the name, address, daytime telephone number, and email
address at which the nominator can be contacted.
HHS strives to ensure that the membership of HHS federal advisory
committee is fairly balanced in terms of points of view presented and
the committees function. Every effort is made to ensure that the views
of women, all ethnic and racial groups, and people with disabilities
are represented on HHS federal advisory committees and, therefore, the
Department encourages nominations of qualified candidates from these
groups. The Department also encourages geographic diversity in the
composition of the Committee. Appointment to this Committee shall be
made without discrimination on basis of age, race, ethnicity, gender,
sexual orientation, disability, and cultural, religious, or
socioeconomic status.
Dated: September 26, 2013.
Bahar Niakan,
Director, Division of Policy and Information Coordination.
[FR Doc. 2013-24304 Filed 10-2-13; 8:45 am]
BILLING CODE 4165-15-P